Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL
Condition: Lymphoma, Non-Hodgkin Intervention: Biological: anti-CD19 FasT CAR-T cells Sponsors: Xinqiao Hospital of Chongqing; Gracell Biotechnologies (Shanghai) Co., Ltd; 920th Hospital of Joint Logistics Support Force; The Second Affiliated Hospital of Chongqing Medical University; The Affiliated Hospital Of Guizhou Medical University; The Second Affiliated Ho spital of Kunming Medical University; Chongqing University Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials